Mixed
The gut-microbiome derived metabolite 3-(4-hydroxyphenyl)lactate is significantly associated with hepatic fibrosis and steatosis in NAFLD, sharing a significant genetic determination with these liver conditions.
This research highlights that a specific gut-derived metabolite, 3-(4-hydroxyphenyl)lactate, is linked to liver scarring (fibrosis) and fat accumulation in NAFLD. While this is a biomarker finding rather than a direct treatment, it suggests that modulating gut microbiome composition or function could be a future therapeutic target for managing NAFLD progression. Patients should focus on general gut health through fiber-rich diets and avoiding unnecessary antibiotics, as these support a healthy microbiome, though specific 'probiotic' prescriptions for this metabolite are not yet established.
Among them, only one microbial metabolite, 3-(4-hydroxyphenyl)lactate, remained consistent and statistically significantly associated with liver fibrosis in the discovery and validation cohort... The share genetic determination of 3-(4-hydroxyphenyl)lactate with hepatic steatosis was RG:0.57... and with fibrosis was RG:0.54...
Why this rating
The study uses a robust twin/family design for heritability, a large discovery cohort, and an independent biopsy-proven validation cohort, providing strong observational evidence, though it is not an interventional trial.
Source
Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD
Cyrielle Caussy et al. · Hepatology · 2018
DOI 10.1002/hep.29892
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →